好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

No Differences in the Proportions of Immune Cells in CSF of Patients with Neurosarcoidosis and Multiple Sclerosis
Autoimmune Neurology
P6 - Poster Session 6 (11:45 AM-12:45 PM)
8-014

To compare the proportions of immune cells in CSF among patients with neurosarcoidosis (NS) and multiple sclerosis (MS).

MS and NS have different pathogenesis but overlap in their clinical presentations and cerebrospinal fluid (CSF) findings. We hypothesized that immune cell profiles and CD4/CD8 ratios in CSF may help differentiate the two disorders.

NS patients evaluated at NYU MS Care Center with available CSF flow were age-, sex-, and race/ethnicity- matched to patients with MS. Proportions of immune cells in CSF were analyzed with flow cytometry (BD FACSCanto™ and FACSCanto™ II Cell Analyzers, BDBiosciences, San Jose, CA) and manually verified by a board-certified hematopathologist. 

19 patients with NS had available CSF flow cytometry (age: 55.9±10.8 years; 68% female; 63% African American; 68% on immunomodulatory medication at the time of CSF collection). Compared to matched MS patients, the patients with NS had significantly higher leukocyte count in CSF (60.8±116.3 v. 2.1±2.6 cells/mm³, p=0.034), higher protein (124.5±129.0 v. 35.7±19.6 mg/dL, p= 0.0053), and lower number of CSF-restricted oligoclonal bands (1.7±2.4 v. 7.7±5.2, p=0.0001), while glucose and IgG index were similar. On CSF flow cytometry, NS patients had 77%±17% small T-lymphocytes, v. 80%±11% in MS (p=0.52); 3%±4% small mature B lymphocytes, v. 2%±2% for MS (p=0.34); 4%±3% NK cells, v. 3%±5% in MS (p=0.46); 9%±12% monocytes, v. 9%±8% for MS (p=1.0). CD4/CD8 ratio in NS - 4.2:1±1.6:1 - was non-significantly higher than in MS - 3.3:1±1.4:1 (p=0.09). Kappa/lambda ratios in NS and MS were very similar: 1.6:1±0.5:1 v. 1.5:1±0.6 in MS (p=0.51).

CSF of NS patients differed from MS in total leukocyte count, protein and OCB, but not in the proportion of immune cells. Neither the CD4/CD8 ratio nor the proportion of mature B lymphocytes helped discriminate between the two diseases. 

Authors/Disclosures
Angie H. Kim
PRESENTER
Ms. Kim has nothing to disclose.
Arnaldo A. Arbini, MD Dr. Arbini has nothing to disclose.
Ilya Kister, MD, FAAN (NYU School of Medicine) Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.